Lincoln Pharmaceuticals Limited

616.85

INR
-12.75(-2.03%)
As of November 14, 2024 10:00:00 AM

Lincoln Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 614
High: 654.1

All time High

790.85

Price Change 1h

+₹-13.70 +-2.17%

Price Change 1d

+₹-13.70 +-2.17%

Price Change 1w

+₹-65.05 +-9.54%

Lincoln Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

1364.72 Cr

About Lincoln Pharmaceuticals Limited Share

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1687

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lincoln Pharmaceuticals consolidated net profit declines 4.77% in the September 2024 quarter
  • Lincoln Pharmaceuticals Ltd reports Net Profit of Rs. 50.03 crore in H1 FY25, growth of 7.55 Percent Y-o-Y
  • Lincoln Pharmaceuticals' Stock Reaches 52-Week High, Outperforms Sector and Sensex
  • Lincoln Pharma reports 28% growth in net profit
  • Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 23.67 crore in Q1 FY25, growth of 24.51 Percent Y-o-Y

FAQs

Lincoln Pharmaceuticals Limited

616.85

INR
-12.75(-2.03%)
As of November 14, 2024 10:00:00 AM

Lincoln Pharmaceuticals Limited Share Price Information

24 hour Low and High

Low: 614
High: 654.1

All time High

790.85

Price Change 1h

+₹-13.70 +-2.17%

Price Change 1d

+₹-13.70 +-2.17%

Price Change 1w

+₹-65.05 +-9.54%

Lincoln Pharmaceuticals Limited Market Information

Exchange

NSE

Market Cap

1364.72 Cr

About Lincoln Pharmaceuticals Limited Share

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1687

CEO

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Lincoln Pharmaceuticals consolidated net profit declines 4.77% in the September 2024 quarter
  • Lincoln Pharmaceuticals Ltd reports Net Profit of Rs. 50.03 crore in H1 FY25, growth of 7.55 Percent Y-o-Y
  • Lincoln Pharmaceuticals' Stock Reaches 52-Week High, Outperforms Sector and Sensex
  • Lincoln Pharma reports 28% growth in net profit
  • Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 23.67 crore in Q1 FY25, growth of 24.51 Percent Y-o-Y

FAQs